Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 

 

 
 
Gosia Trynka, Group Leader at The Sanger Institute and Experimental Science Director at Open Targets, about the importance of cellular context to the translation of genomic and transcriptomic insights into actionable targets.
 

 
John Moffat, senior scientist in Biochemical and Cellular Pharmacology at Genentech, discusses the target validation and prioritization opportunities revealed at the crossroads of target-focused and phenotypic profiling approaches.
 

 
Walter Kolch, co-founder and director of Systems Biology Ireland discusses the merits of a network approach to target validation and why probing clinical samples early is critical to increasing drug development success.
 

 
Mica Zaragoza, Consultant, Global Custom Manufacturing & OEM Solutions, Promega Corporation, discusses the company's standard and custom product development and consultative services associated with biotechnology and molecular biology research and drug discovery.
 

 
Dr. George Karlin-Neuman, Director of Scientific Affairs with the Bio-Rad Digital Biology Center in Pleasanton, California.is Dr. George Karlin-Neuman, Director of Scientific Affairs with the Bio-Rad Digital Biology Center in Pleasanton, California.
 

 
O2 Control in the Cell Culture Incubator, Carl Radosivech, Panasonic Healthcare Corporation of North America.
 

 
Guest commentary by Bill White, CEO Offenberger and White.
 


PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.